4//SEC Filing
Bazemore Todd 4
Accession 0001415889-25-015679
CIK 0001479419other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:00 PM ET
Size
6.4 KB
Accession
0001415889-25-015679
Insider Transaction Report
Form 4
KALA BIO, Inc.KALA
Bazemore Todd
SEE REMARKS
Transactions
- Sale
Common Stock
2025-06-03$3.74/sh−3,390$12,679→ 87,757 total
Holdings
- 1(indirect: By son)
Common Stock
Footnotes (3)
- [F1]This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 10, 2020 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units ("RSUs") granted on May 31, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $4.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]Includes 51,963 unvested RSUs.
Documents
Issuer
KALA BIO, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001605767
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:00 PM ET
- Size
- 6.4 KB